This week in The Fin podcast, technology writer Nick Bonyhady and health editor Jill Margo on how Ozempic has upended the weight-loss industry, the companies trying to make money from it and the health risks threatening to derail its meteoric rise.

Further reading: 

• The weight loss cycle: out with Jenny Craig, in with Ozempic Depending who you ask, Ozempic is “phenomenal” for patients or a “dangerous” way of losing weight. Either way, its arrival heralds a new model of medicine.
• Eucalyptus changes tune and begins selling Ozempic Australia’s biggest weight loss drug selling start-up, Eucalyptus, has begun selling Ozempic after previously insisting it only sold medications specifically approved to help people shed kilograms.

If this episode has raised any concerns for you, help is available.

Call Lifeline on: 13 11 14

See omnystudio.com/listener for privacy information.